Altered cholesterol synthesis as a mechanism involved in methyl isobutyl ketone-potentiated experimental cholestasis

Toxicology and Applied Pharmacology

Volumn 147, Issue 2, 1997, Pages 281-288

  Duguay, Alexandra ^a   Plaa, Gabriel L ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bilirubin; Cholestasis; Cholesterol; Ketone; Manganese; Membrane; Methyl isobutyl ketone

Indexed keywords

4 METHYL 2 PENTANONE; BILIRUBIN; CHOLESTEROL; MANGANESE; MEVALONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; INTRAHEPATIC BILE DUCT; LIVER CELL MEMBRANE; LIVER CYTOSOL; LIVER MICROSOME; LIVER MITOCHONDRION; LIVER SINUSOID; MALE; NONHUMAN; RAT;

EID: 0031413468     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8274     Document Type: Article

References (37)

1. ACGIH, 1994, Threshold limit values for chemical substances and physical agents and biological exposure indices for 1994-95, ACGIH, Cincinnati.
2. Ayotte P., Plaa G. L. Modification of biliary tree permeability in rats treated with a manganese-bilirubin combination. Toxicol. Appl. Pharmacol. 84:1986;295-303.
3. Bartlett G. R. Phosphorus assay in column chromatography. J. Biol. Chem. 234:1959;466-468.
4. Browning E. Ketones. Toxicity and Metabolism of Industrial Solvents. 1965;Elsevier, Amsterdam. p. 412-432.
5. Couri D., Hetland L. B., Abdel-Rahman M. S., Weiss H. The influence of inhaled ketone solvent vapors on hepatic microsomal biotransformation activities. Toxicol. Appl. Pharmacol. 41:1977;285-289.
6. Dahlstrom-King L., Couture J., Plaa G. L. Effect of inhibition of protein synthesis on cholestasis induced by taurolithocholate, lithocholate and a manganese-bilirubin combination in the rat. Biochem. Pharmacol. 38:1989;2543-2549.
7. Dahlstrom-King L., Couture J., Plaa G. L. Functional changes of the biliary tree associated with experimentally induced cholestasis: Sulfobromophthalein on manganese-bilirubin combinations. Toxicol. Appl. Pharmacol. 108:1991;559-567.
8. Dahlstrom-King L., Plaa G. L. Influence of agents affecting monooxygenase activity on taurolithocholic acid-induced cholestasis. Toxicol. Lett. 63:1992;243-252.
9. De Lamirande E., Tuchweber B., Plaa G. L. Hepatocellular membrane alteration as a possible cause of manganese-bilirubin-induced cholestasis. Biochem. Pharmacol. 30:1981;2305-2312.
10. De Lamirande E., Tuchweber B., Plaa G. L. Morphological aspects of manganese-bilirubin induced cholestasis. Liver. 2:1982;22-27.
11. Dick R. B., Krieg E. F., Setzer J., Taylor B. Neurobehavioral effects from acute exposures to methyl isobutyl ketone and methyl ethyl ketone. Fundam. Appl. Toxicol. 19:1992;453-473.
12. Duguay A., Plaa G. L. Plasma concentrations in methyl isobutyl ketone-potentiated experimental cholestasis after inhalation or oral exposure. Fundam. Appl. Toxicol. 21:1993;222-227.
13. Duguay A., Couture J., Yousef I., Tuchweber B., Plaa G. L. Lipid alteration of hepatic membranes in experimentally induced cholestasis. Can. J. Physiol. Pharmacol. 72:1994;601.
14. Duguay A., Plaa G. L. Ketone potentiation of intrahepatic cholestasis: Effect of two aliphatic isomers. J. Toxicol. Environ. Health. 50:1997;41-52.
15. Duguay A., Yousef I., Plaa G. L. Newly synthesized cholesterol accumulation in bile canalicular membranes after manganese-bilirubin-induced cholestasis. Biochim. Biophys. Acta. 1997.
16. Feuer G., Di Fonzo C. J. Intrahepatic cholestasis: a review of biochemical-pathological mechanisms. Drug Metab. Drug Interact. 10:1992;1-162.
17. Haugland R. P. Molecular probes. Handbook of Fluorescence Probes and Research Chemicals. 1992;Eugene Molecular Probes Inc. Eugene. p. 235-242.
18. Imaoka S., Funae Y. Induction of cytochrome P450 isozymes in rat liver by methyl n-alkyl ketones and n-alkylbenzenes: Effects of hydrophobicity of inducers on inducibility of cytochrome P450. Biochem. Pharmacol. 42:1991;S143-S150.
19. Iregren A., Tesarz M., Wigaeus-Hjelm E. Human experimental MiBK exposure: Effects on heart rate, performance, and symptoms. Environ. Res. 63:1993;101-108.
20. King P. D., Blitzer B. L. Drug-induced cholestasis: Pathogenesis and clinical features. Sem. Liver Dis. 10:1990;316-321.
21. Kobush A., Plaa G. L., du Souich P. Effects of acetone and methyl n-butyl ketone on hepatic mixed-function oxidase. Biochem. Pharmacol. 38:1989;3461-3467.
22. McIntyre J. C., Sleight R. G. Mechanisms of intracellular membrane lipid transport. Curr. Topics Membr. 40:1994;453-481.
23. Meier-Abt P. J. Cellular mechanisms of intrahepatic cholestasis. Drugs. 40:1990;84-97.
24. Oelberg D. G., Lester R. Cellular mechanisms of cholestasis. Annu. Rev. Med. 37:1986;297-317.
25. Plaa G. L. Ketone potentiation and chemical toxicity. Plaa G. L., du Souich P., Erill S. Interactions between Drugs and Chemicals in Industrial Societies. 1987;47-56 Excerpta Medica, Amsterdam.
26. Plaa G. L., Hewitt W. R. Biotransformation products and cholestasis. Popper H., Schaffner F. Progress in Liver Diseases. 1982;179-194 Grune & Stratton, New York.
27. Reichen J. Mechanisms of cholestasis. Tavoloni N., Berk P. D. Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. 1993;665-672 Raven Press, New York.
28. Reinhart M. P. Intracellular sterol trafficking. Experientia. 46:1990;599-610.
29. Spencer P. S., Schaumberg H. H. Feline nervous system response to chronic intoxication with commercial grade of MnBK, MiBK and MEK. Toxicol. Appl. Pharmacol. 37:1976;301-311.
30. Sperry W., Webb M. A revision of the Schoenheimer-Sperry method for cholesterol determination. J. Biol. Chem. 187:1950;97-106.
31. Storch J., Schachter D. Calcium alters the acyl chain composition and lipid fluidity of rat hepatocyte plasma membranesin vitro. Biochim. Biophys Acta. 812:1985;473-484.
32. USTIC, 1985, Synthetic Organic Chemicals, United States Production and Sales.
33. Van Meer G. Lipid traffic in animal cells. Annu. Rev. Cell. Biol. 5:1989;247-275.
34. Vézina M., Plaa G. L. Methyl isobutyl ketone metabolites and potentiation of the cholestasis induced by manganese-bilirubin combination or manganese alone. Toxicol. Appl. Pharmacol. 92:1988;419-427.
35. Voelker D. R. Lipid transport pathways in mammalian cells. Experientia. 46:1990;569-579.
36. Yousef I. M., Tuchweber B. Effect of lithocholic acid on cholesterol synthesis and transport in rat liver. Biochim. Biophys. Acta. 796:1984;336-344.
37. Zimmerman H. Update of hepatotoxicity due to classes of drugs in common clinical use. Sem. Liver Dis. 10:1990;322-338.